Abstract: The concept of the retrograde lymphatic spread of cancer cells appears to account for a subset of the essential mechanisms of cancer metastasis in various organs. However, no adequate data currently exist to illustrate the pathology of the retrograde lymphatic metastasis of cancer cells in human bodies. To shed light on this phenomenon, we report a case of a 63-year-old Japanese man who underwent an esophagectomy and lymph node dissection for early-stage esophageal cancer.
INTRODUCTION
L ymph node (LN) metastasis is an important prognostic predictor for esophageal squamous cell carcinoma. 1 The bidirectional or skip nodal spread of cancer cells is thought to be a key feature of lymphatic metastasis in patients with thoracic esophageal squamous cell carcinoma. 1, 2 Thus, it is important to discover the mechanisms of the lymphatic metastasis of esophageal cancer.
The concept of the retrograde lymphatic spread of cancer cells appears to account for a subset of the essential mechanisms of cancer metastasis in not only the esophagus but also various other regions, such as the lungs, pleura, mediastinum, heart, pericardium, axilla, spleen, retroperitoneum, perinephritic space, testis, ovary, prostate, penis, and vulva. [3] [4] [5] However, questions remain regarding the term retrograde lymphatic metastasis, which appears in the literature but may sometimes be incorrectly used to describe anterograde lymphatic metastasis to an unusual site due to anatomical variation in the lymphatic distribution and/or caused by the alteration of the lymphatic distribution by a particular pathological condition.
An anterograde lymph flow can be defined as a flow in the direction of a lymphatic valve, and a retrograde lymph flow can be defined as a flow against the direction of a lymphatic valve. To the best of our knowledge, if these definitions are rigorously followed, no adequate data currently exist to illustrate the pathology of the retrograde lymphatic metastasis of cancer cells in human bodies. Thus, our central question is whether the retrograde lymphatic spread of cancer cells actually occurs in human bodies.
In this report, we describe an illustrative case of esophageal cancer in which cancer cells exhibited retrograde lymphatic spread. We also discuss the mechanisms and significance of this phenomenon.
METHODS
Written informed consent for this case study was obtained from the patient. The patient's clinical information was evaluated by board-certified surgeons (YO and ST) and internists (TA and TT). Surgically excised materials were immediately fixed in 20% neutral buffered formalin for routine histological examination and evaluated by attending pathologists (HO and TN). Immunohistochemistry was performed using a D2-40 antibody (D2-40; Nichirei Bioscience; Tokyo, Japan), a detection kit (Histofine Simple Stain MAX PO, MULTI; Nichirei Bioscience), and an autostainer (Histostainer; Nichirei Bioscience) according to the manufacturer's instruction.
RESULTS

Clinical Findings
A 63-year-old Japanese man was referred to our hospital for a detailed examination and treatment of esophageal cancer that had been detected during his health checkup. His history was unremarkable except for hypertension, which had been well controlled by an antihypertensive drug. He had been a smoker (Brinkman index ¼ 1290) and had consumed approximately 34-54 g of alcohol per day for 43 years. His mother had suffered from gastric cancer, and his elderly brother had suffered from bladder cancer. No metastatic lesions were detected in his preoperative work-up, which consisted of systemic computed tomography ( Figure 1 ) and 18 F-fluorodeoxyglucose positron emission tomography.
The patient underwent subtotal esophagectomy and LN dissection with assistance from a da Vinci surgical system followed by a thoracoscopy and anastomosis of the stomach to the cervical esophagus via the posterior portion of the mediastinum, with the gastric tube reconstructed by handassisted laparoscopic surgery. His postoperative course was uneventful. He has been regularly followed without adjuvant therapy and has remained free from disease recurrence for 38 months since his operation.
Pathological Findings
After the operation, histopathological examination was performed on the excised esophagus and dissected LNs by total segmentation, and a final diagnosis of the lesion was generated ( Figure 2 ). This lesion was a single tumor 47 Â 38 mm in size located in the middle to the lower thoracic portion of the esophagus. The tumor was a superficial (0 -Ip þ IIc type), well-differentiated squamous cell carcinoma with invasion into 2/3 of the depth of the submucosal layer (500 mm) from the inferior border of the muscularis mucosae, and it had negative surgical margins, no intramural metastasis and no LN metastases (pN0; #1: right cardiac LNs The tumor was categorized as T1bN0M0 and stage I using the Japanese classification of esophageal cancer. 6 Venous invasion was confirmed in 1 small vein in the esophagus by Elastica-van Gieson staining. In particular, distant from the primary lesion, a single lymphatic vessel running along the lamina muscularis had been invaded by cancer cells (Figure 3 ). The nature of lymphatics was immunohistochemically confirmed using a FIGURE 1. A contrast enhanced computed tomographic image of the thoracic organs demonstrates no remarkable changes, except for slight thickening of the wall in the lower thoracic portion of the esophagus (arrow). D2-40 antibody. In this lymphatic vessel, 2 cancer cell clusters were observed. Notably, intralymphatic cancer cells had spread against the direction of backflow prevention valves. Moreover, serial tissue sections revealed that intralymphatic cancer cells had skipped beyond these valves without morphological destruction of the valves. The lymphatic lumen was dilated, and the cancer cell clusters appeared to be partially attached to the endothelium. The distance from the primary lesion to the distal margin of the intralymphatic cancer cell cluster was approximately 5 mm. The upward lymphatic vessel located after the cancer cell cluster that could be tracked by the tissue sections was approximately 100 mm in length, and it became smaller in diameter, accompanied by a closed lymphatic valve, and was no longer invaded by cancer cells.
DISCUSSION
In the present case, one could consider the possibility of the anterograde lymphatic spread of cancer cells from other lymphatics. However, this possibility was excluded for the following reasons: the esophagus was histopathologically inspected by total segmentation, and only a single lymphatic vessel had been invaded by cancer cells; there was no LN metastasis; and no neoadjuvant therapy was administered to the patient. Moreover, the possibility of the artificial implantation of cancer cells was excluded for the following reasons: during the operation, surgeons gently excised the esophagus without strong pressure and after formalin fixation, pathologists gently cut the esophagus with a disposable blade without strong pressure, and the blade surface was cleaned with clear gauze following each cut.
The mechanisms of lymphatic valve opening and closure can be depicted by considering the following fluid pressures at different locations around a valve 7 : the pressure in front of the valve (P1); the pressure in the funnel-shaped space between valve faces (P2); and the pressure in the pocket (P3) (Figure 4 The mechanisms of the retrograde lymphatic spread of cancer cells in the current case can be explained by the following phenomena: an increase in downstream intralymphatic pressure caused by lymphatic obstruction following cancer invasion or by an extrinsic lymph pump that depends on adjacent tissue movements, such as swallowing, esophageal peristalsis, arteriolar vasomotion, arteriolar pulsation, or respiration 7 ; contractile dysfunction of the lymphatic wall caused by a tumor thrombus or by physiologically active substances, such as VEGF-C, which may have been released by cancer cells or lymphatic endothelial cells 8, 9 ; and intermittent regurgitation of the lymphatic valve caused by lymphatic ectasia or by the adhesion of cancer cells to lymphatic endothelial cells, presumably via adhesion-related molecules, such as ICAM-1, which have been expressed by either type of cell. 10, 11 The anatomical distribution in the middle and posterior mediastinal lymphatics is complex. 12 Characteristically, lymphatics originating from the lower thoracic esophagus share with lymphatics originating from the pulmonary ligament, which has lymphatic stomata and a rich lymphatic network.
12-14 These lymphatics connect with LNs of the tracheal bifurcation and with celiac LNs to form lymphatic chains. 15 In addition, lymphatics originating from the thoracic esophagus frequently drain into the thoracic duct directly without intervening LNs. 12, 13, 16, 17 Notably, the human thoracic duct has multiple collateral branches (8.75 AE 3.89; mean AE SD) where anterograde 1-leaflet valves, retrograde 1-leaflet valves or oppositely arrayed 2-leaflet valves are frequently present, allowing for bidirectional lymph flow and accommodating the flow rate of the thoracic duct based on physiological or pathological conditions. 18, 19 These characteristics can account for part of the basis of bidirectional or skip nodal metastasis in esophageal cancer.
Recent experimental studies have demonstrated that the rerouting of lymph flow is a key feature in the development of lymphatic metastases. 8 Larger metastases within the sentinel LN can obstruct lymphatic drainage, rerouting lymph flow toward another LN that is metastasis-free, which can lead to a false-negative sentinel LN. 20, 21 At a later stage, this LN accepts cancer cells via rerouted flow from the metastatic sentinel LN. 8 However, the means by which lymphatic rerouting occurs remain incompletely elucidated. Certain investigators have speculated that the rerouting of lymph flow involves anterograde travel via newly generated bypassing and collateral lymphatics. 8 In contrast, the present case study suggests that such rerouting can also occur via pre-existing lymphatic vessels in a retrograde manner.
There has been keen interest concerning the effect of extended lymphadenectomy and the usefulness of sentinel node navigation surgery for esophageal cancers among researchoriented clinical investigators. [22] [23] [24] [25] [26] However, different procedures under different conditions by various institutions often make a comparison of studies difficult, leading to indefinite conclusions. 27 We have more to accomplish before standardization of clinical practices against the lymphatic system. Further elucidation of human lymphatic pathology will help to develop and standardize better therapeutic strategies in esophageal cancers.
In summary, our study demonstrated that the retrograde lymphatic spread of cancer cells occurs against the direction of lymphatic valves without structural destruction of these valves. The present study may not only provide a scientific basis for the concept of retrograde lymphatic metastasis but also explain a portion of the complexities associated with the lymphogenous metastasis of esophageal cancer. 
